CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Erratum: Correction of Figures. The Time Course Changes in Bone Metabolic Markers after Administering the Anti-Receptor Activator of Nuclear Factor-Kappa B Ligand Antibody and Drug Compliance among Patients with Osteoporosis
Kazuhide Inage, Sumihisa Orita, Kazuyo Yamauchi, Yoshihiro Sakuma, Go Kubota, Yasuhiro Oikawa, Takeshi Sainoh, Jun Sato, Kazuki Fujimoto, Yasuhiro Shiga, Kazuhisa Takahashi, Seiji Ohtori
Asian Spine J. 2015;9(6):999-1000.   Published online December 8, 2015
DOI: https://doi.org/10.4184/asj.2015.9.6.999

Excel Download

Erratum: Correction of Figures. The Time Course Changes in Bone Metabolic Markers after Administering the Anti-Receptor Activator of Nuclear Factor-Kappa B Ligand Antibody and Drug Compliance among Patients with Osteoporosis
Asian Spine Journal. 2015;9(6):999   Crossref logo
Link1

The Time Course Changes in Bone Metabolic Markers after Administering the Anti-Receptor Activator of Nuclear Factor-Kappa B Ligand Antibody and Drug Compliance among Patients with Osteoporosis
Asian Spine Journal. 2015;9(3):338   Crossref logo
Link1

SERUM SOLUBLE RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B LIGAND, OSTEOPROTEGERIN, AND SERUM SOLUBLE RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B LIGAND/OSTEOPROTEGERIN RATIO IN FEMALE PATIENTS WITH RHEUMATOID ARTHRITIS
European Journal of Internal Medicine. 2011;22:S47   Crossref logo
Link1 Link2

Administration of anti-receptor activator of nuclear factor-kappa B ligand (RANKL) antibody for the treatment of osteoporosis was associated with amelioration of hepatitis in a female patient with growth hormone deficiency: a case report
BMC Endocrine Disorders. 2016;16(1):   Crossref logo
Link1 Link2 Link3

Osteoprotective Effect of Cimiracemate in Glucocorticoid-Induced Osteoporosis by Osteoprotegerin/Receptor Activator of Nuclear Factor κ B/Receptor Activator of Nuclear Factor Kappa-Β Ligand Signaling
Pharmacology. 2019;103(3-4):163-172   Crossref logo
Link1 Link2

Receptor activator of nuclear factor kappa B ligand
Lexikon der Medizinischen Laboratoriumsdiagnostik. 2019;2036-2037   Crossref logo
Link1

Receptor activator of nuclear factor kappa B ligand
Lexikon der Medizinischen Laboratoriumsdiagnostik. 2017;1-1   Crossref logo
Link1

Receptor activator of nuclear factor-κB ligand and osteoprotegerin: maintaining the balance to prevent bone loss
Clinical Interventions in Aging. 2010;345   Crossref logo
Link1

Receptor activator of nuclear factor kappa B ligand antagonists inhibit tissue inflammation and bone loss in experimental periodontitis
Journal of Clinical Periodontology. 2011;38(11):1029-1036   Crossref logo
Link1

Receptor Activator for Nuclear Factor kappa B Ligand (RANKL) as an osteoimmune key regulator in bone physiology and pathology
Acta Histochemica. 2011;113(2):73-81   Crossref logo
Link1 Link2